|
Patent landscape, scope, and claims: |
United States Patent 4,158,055: Scope, Claims, and U.S. Patent Landscape
What is US 4,158,055 and what does it cover?
US Patent 4,158,055 (United States) is directed to a specific chemical composition and/or chemical process claim set, typical of late-1970s U.S. chemical patents. A claim-by-claim scope analysis and a prosecution-style landscape read require the exact published patent text (claims and specification). Without the patent’s claim text, any assessment of scope or landscape would be non-verifiable.
No claim text or bibliographic record was provided in the prompt, and the source material needed to produce an accurate claim chart and legal landscape cannot be derived from the patent number alone in this environment.
What are the independent and dependent claims, and how broad is each?
A complete claim-scope answer requires:
- the verbatim claim set (independent claims and all dependent claims),
- the definitions used in the specification,
- and the claim construction hooks (terms defined in the description, preferred ranges, and examples).
With no claim text available here, a precise scope and breadth assessment cannot be produced.
What claim elements define the protected subject matter?
A defensible element-level analysis requires:
- enumerated claim limitations (structure, substituents, functional parameters, ratios, process steps, catalysts, temperatures/pressures, purification steps),
- any Markush or alternative claim branches,
- and any composition vs. method bifurcations.
Those limitations are not accessible from the patent number alone in this context.
How does US 4,158,055 map onto likely drug products or competitors?
A product mapping analysis requires:
- the identity of the active compound(s) (or key intermediates),
- the salt forms (if any), polymorph coverage, and formulation boundaries,
- and the process fingerprints if method claims exist.
Without the specification and claims, no legally meaningful mapping can be made.
What is the U.S. patent landscape around US 4,158,055?
A high-quality landscape for a specific U.S. drug patent normally includes:
- family members (continuations, divisionals, continuations-in-part),
- earlier priority patents and their claim scope,
- later U.S. filings covering improved analogs, formulations, salts, stereochemistry, polymorphs, dosing regimens, and manufacturing processes,
- FDA-linked exclusivities only when relevant to the compound (NDA/BLA and Orange Book),
- and expiration and terminal disclaimer structures.
Those items require the underlying bibliographic record and/or text. With no provided record, the landscape cannot be completed.
Can US 4,158,055 be treated as composition, method, or both?
That determination requires claim classification:
- composition claims (compound, salt, formulation, dosage form),
- method claims (use, treatment method),
- manufacturing process claims (steps, conditions, yields).
Claim text is not present, so classification would be speculative.
What does the claim language likely restrict (chemical structure, parameters, or process steps)?
Late-1970s chemical patents often restrict scope via at least one of:
- a defined chemical structure class (substituent patterns, ring systems, stereochemistry),
- explicit physicochemical parameters (solubility, melting point, purity, activity metrics),
- explicit process steps/conditions (reactant identities, catalysts, temperatures, times).
However, without the verbatim claim language, no specific restrictions can be stated.
Key Takeaways
- A verifiable scope and claims analysis of US 4,158,055 requires the patent’s claim text and bibliographic record.
- No claim language, independent/dependent claim structure, or specification definitions were provided, so no accurate breadth, element mapping, or landscape can be produced without fabricating facts.
FAQs
-
What documents are needed to analyze a U.S. drug patent’s scope accurately?
The verbatim claims, definitions from the specification, and the complete bibliographic record.
-
Why can’t the patent number alone support a claim chart?
Claim scope depends on the exact claim language and defined terms, which are not derivable from the number itself in this context.
-
What parts of a claim control breadth most often in chemical drug patents?
Defined compound structure, Markush alternatives, functional limitations, and explicit process or parameter limits.
-
How is “landscape” usually built for a specific U.S. drug patent?
By linking family members, earlier and later related filings, and product-relevant claim territories such as salts, polymorphs, formulations, and process improvements.
-
Can we assess infringement risk without claim text?
Infringement risk requires claim-element comparison to the accused product or process, which depends on the exact limitations.
References
[1] United States Patent 4,158,055.
More… ↓
⤷ Start Trial
|
